Publication | Open Access
KL‐6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis
94
Citations
27
References
2011
Year
The level of serum KL-6 may serve as measure of ILD in patients with PM/DM and is a promising biomarker for use in clinical practice to assess clinical response to treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1